copper gluconate has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallardo-Pérez, JC; Marín-Hernández, A; Moreno-Sánchez, R; Rivero-Segura, NA; Rodríguez-Enríquez, S | 1 |
| Cao, Q; Fu, SY; Li, Y; Wang, FY; Wang, LH; Wang, NN; Wang, YT; Wu, CF; Yang, JY | 1 |
2 other study(ies) available for copper gluconate and Invasiveness, Neoplasm
| Article | Year |
|---|---|
GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids.
Topics: 3T3 Cells; Adult; Aged; Aged, 80 and over; Animals; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Movement; Cell Proliferation; Cross-Sectional Studies; Cytokines; Epithelial-Mesenchymal Transition; Female; Gluconates; Glucose-6-Phosphate Isomerase; Humans; Lactic Acid; MCF-7 Cells; Mice; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Phenotype; Spheroids, Cellular; Sugar Phosphates | 2014 |
Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Disulfiram; Drug Synergism; ErbB Receptors; Gefitinib; Glioma; Gluconates; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Quinazolines; Signal Transduction; src-Family Kinases; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |